Financial Comparison: Citius Pharmaceuticals (NASDAQ:CTXR) & Takeda Pharmaceutical (NYSE:TAK) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Independent Director nominee expected to be elected at Annual Shareholders Meeting in March 2024
CRANFORD, N.J., Jan. 23, 2024 /PRNewswire/ Citius Pharmaceuticals, Inc. , a late-stage.
Citius Pharmaceuticals (CTXR) Appoints Robert J Smith to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today announced the nomination of seasoned pharmaceutical.
Citius Pharmaceuticals, Inc (NASDAQ:CTXR) Short Interest Up 8 6% in December theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.